Back to News
Silversmith’s Jeff Crisan Named to GrowthCap’s Top 25 Healthcare Investors of 2022Read More Here
Silversmith Capital Partners’ Jeff Crisan was named as a Top 25 Healthcare Investor of 2022 by GrowthCap Advisory. With over 800 nominees this year, GrowthCap evaluated each based on the quality of feedback they received from portfolio company CEOs, firm colleagues and peers in the industry, as well as their own proprietary research. The 2022 list represents a diverse set of individuals with demonstrated exceptional performance in the areas of investment selection, value creation, and ESG engagement.
As noted by GrowthCap, “Healthcare plays a critical role in the quality of our lives, underpins business and economic activity, and ultimately determines the state of our world. This year’s awardees were selected based on deal experience and track record, strategic and operational capabilities provided to portfolio companies, unique and differentiated attributes, as well as contributions to ESG, DEI, charitable work, and overall industry advancement.”
Jeff co-founded Silversmith Capital Partners in 2015. In his role as Managing Partner, Jeff focuses on investments in Healthcare IT & Services. Within Healthcare IT, Jeff partners with talented leaders of proven, high growth software and data companies that can either materially improve clinical outcomes or reduce administrative inefficiency within all segments of the U.S. healthcare ecosystem. Jeff’s healthcare services investments are centered around innovative care delivery models oriented towards value-based care that can be scaled both organically and through M&A.
With more than 20 years investing experience, Jeff has led many of the firm’s key healthcare investments including Iodine Health, LifeStance Health (Nasdaq: LFST), MediQuant, Nordic, Panalgo (acquired by MMIT/Evaluate), Partners Surgical, Sound Physicians, Upperline Health, US Health Partners and Within3. Some of Jeff’s notable investments prior to founding Silversmith include ABILITY Network, Liberty Dialysis, Liazon and MedHOK.
Read more about Jeff and his fellow honorees here.